Sorry, you need to enable JavaScript to visit this website.

Study on Use of a Modified RNA Vaccine for Influenza in Healthy Participants

 A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza in Healthy Individuals

Category & Conditions: Vaccine-related Conditions
Medicine: PF-07252220
ClinicalTrials.gov Identifier (NCT): NCT05052697
Protocol ID: C4781001
PrintDownload
Open Plain Language Summary Result: Click here